JSON
Mohammadi MR, Riazifar M, Pone EJ, Yeri A, Van Keuren-Jensen K, Lässer C, Lotvall J, Zhao W
Methods 177 (-) 50-57 [2020-05-01; online 2019-10-25]
Mesenchymal stem or stromal cells are currently under clinical investigation for multiple diseases. While their mechanism of action is still not fully elucidated, vesicles secreted by MSCs are believed to recapitulate their therapeutic potentials to some extent. Microvesicles (MVs), also called as microparticles or ectosome, are among secreted vesicles that could transfer cytoplasmic cargo, including RNA and proteins, from emitting (source) cells to recipient cells. Given the importance of MVs, we here attempted to establish a method to isolate and characterize MVs secreted from unmodified human bone marrow derived MSCs (referred to as native MSCs, and their microvesicles as Native-MVs) and IFNγ stimulated MSCs (referred to as IFNγ-MSCs, and their microvesicles as IFNγ-MVs). We first describe an ultracentrifugation technique to isolate MVs from the conditioned cell culture media of MSCs. Next, we describe characterization and quality control steps to analyze the protein and RNA content of MVs. Finally, we examined the potential of MVs to exert immunomodulatory effects through induction of regulatory T cells (Tregs). Secretory vesicles from MSCs are promising alternatives for cell therapy with applications in drug delivery, regenerative medicine, and immunotherapy.
Integrated Microscopy Technologies Gothenburg [Service]
PubMed 31669353
DOI 10.1016/j.ymeth.2019.10.010
Crossref 10.1016/j.ymeth.2019.10.010
mid: NIHMS1542355
pmc: PMC7182501
pii: S1046-2023(19)30226-9